Literature DB >> 30983138

Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient-centered review.

Brianna Johnson-Rabbett1, Elizabeth R Seaquist1.   

Abstract

Hypoglycemia is a frequent occurrence in patients with diabetes who are treated with insulin and insulin secretagogues. Hypoglycemia is the limiting factor that prevents patients from achieving the glycemic control known to reduce the microvascular complications of diabetes. Recurrent episodes of hypoglycemia can lead to impaired awareness of hypoglycemia where the first symptom of a low blood sugar is unconsciousness. The fear of hypoglycemia has a significant effect on the quality of life of patients and their families. In the acute setting, hypoglycemia can kill, and clinical trials have demonstrated that a single episode of severe hypoglycemia increases the risk of subsequent mortality and cardiovascular events. Clinicians must make efforts to recognize and prevent hypoglycemia in order to prevent the adverse events associated with this event. Patient education is central to these efforts. Recent developments in glucose monitoring and drug development have provided more approaches that can be used to reduce the risk of hypoglycemia in patients with diabetes.
© 2019 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  cardiovascular disease; diabetes; hypoglycemia; insulin; mortality; 低血糖; 心血管疾病; 死亡率; 糖尿病; 胰岛素

Mesh:

Substances:

Year:  2019        PMID: 30983138     DOI: 10.1111/1753-0407.12933

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  11 in total

1.  Astrocyte regulation of cerebral blood flow during hypoglycemia.

Authors:  Amy R Nippert; Pei-Pei Chiang; Armani P Del Franco; Eric A Newman
Journal:  J Cereb Blood Flow Metab       Date:  2022-03-17       Impact factor: 6.960

Review 2.  Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment.

Authors:  Luke R Lemmerman; Devleena Das; Natalia Higuita-Castro; Raghavendra G Mirmira; Daniel Gallego-Perez
Journal:  Trends Endocrinol Metab       Date:  2020-03-04       Impact factor: 12.015

3.  Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial.

Authors:  Takashi Kadowaki; Guang Wang; Julio Rosenstock; Daisuke Yabe; Yongde Peng; Keizo Kanasaki; Yiming Mu; Michaela Mattheus; Annett Keller; Tomoo Okamura; Odd Erik Johansen; Nikolaus Marx
Journal:  Diabetol Int       Date:  2020-06-27

4.  Litchi-related Hypoglycemia: A Public Health Challenge, an Endocrine Opportunity.

Authors:  Deep Dutta; Deepak Khandelwal; Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2019 May-Jun

5.  Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.

Authors:  Mark A Espeland; Richard E Pratley; Julio Rosenstock; Takashi Kadowaki; Yutaka Seino; Bernard Zinman; Nikolaus Marx; Darren K McGuire; Knut Robert Andersen; Michaela Mattheus; Annett Keller; Maria Weber; Odd Erik Johansen
Journal:  Diabetes Obes Metab       Date:  2020-12-06       Impact factor: 6.577

6.  Nocturnal Hypoglycaemia in Patients with Diabetes Mellitus: Database Analysis of a Cohort Using Telemedicine Support for Self-Monitoring of Blood Glucose over a 10-Year-Long Period.

Authors:  Gyorgy Jermendy; Agnes Kecskes; Attila Nagy
Journal:  Medicina (Kaunas)       Date:  2021-02-14       Impact factor: 2.430

Review 7.  A new look at brittle diabetes.

Authors:  Irl B Hirsch; Linda M Gaudiani
Journal:  J Diabetes Complications       Date:  2020-06-02       Impact factor: 2.852

8.  An In Silico and an In Vitro Inhibition Analysis of Glycogen Phosphorylase by Flavonoids, Styrylchromones, and Pyrazoles.

Authors:  Sónia Rocha; Natália Aniceto; Rita C Guedes; Hélio M T Albuquerque; Vera L M Silva; Artur M S Silva; Maria Luísa Corvo; Eduarda Fernandes; Marisa Freitas
Journal:  Nutrients       Date:  2022-01-12       Impact factor: 5.717

9.  Repeated hypoglycemia remodels neural inputs and disrupts mitochondrial function to blunt glucose-inhibited GHRH neuron responsiveness.

Authors:  Mitchell Bayne; Alexandra Alvarsson; Kavya Devarakonda; Rosemary Li; Maria Jimenez-Gonzalez; Darline Garibay; Kaetlyn Conner; Merina Varghese; Madhavika N Serasinghe; Jerry E Chipuk; Patrick R Hof; Sarah A Stanley
Journal:  JCI Insight       Date:  2020-11-05

10.  The influence of hypoglycemia and hyperglycemia on the adverse outcome of COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.

Authors:  Yan Yang; Xiumei Fan Dongqiong Chen; Yalin Chen; Hongyan Xie; Chunguang Xie; Lipin Ying
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.